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Abstract  
Low-carbohydrate diets (LCD) have been promoted for weight control and type 2 diabetes 
(T2D) management, based on an emerging body of evidence, including meta-analyses with 
indication of publication bias. Proposed definitions vary between 50 to 130 g/d, or <10% to 
<40% of energy from carbohydrate, with no consensus on LCD compositional criteria. LCDs 
are usually followed with limited consideration for other macronutrients in the overall diet 
composition, introducing variance in the constituent foods, and in metabolic responses. For 
weight management, extensive evidence supports LCDs as a valid weight loss treatment, up to 
1-2 years. Solely lowering carbohydrate intake does not, in the medium/long term, reduce 
HbA1c for T2D prevention or treatment, as many mechanisms interplay. Under controlled 
feeding conditions, LCDs are not physiologically or clinically superior to diets with higher 
carbohydrates for weight-loss, fat loss, energy expenditure or glycaemic outcomes; indeed, all 
metabolic improvements require weight loss. Long-term evidence also links LCD pattern to 
increased cardiovascular disease risks and mortality. LCDs can lead to micronutrient 
deficiencies and increased LDL-cholesterol, depending on food selection to replace 
carbohydrates. Evidence is limited but promising regarding food choices/sources to replace 
high-carbohydrate foods that may alleviate the negative effects of LCDs, demanding further 
insight in the dietary practice of medium to long term LCD followers. Long-term, high-quality 
studies of LCDs with different food sources (animal and/or plant origins) are needed, aiming 
for clinical endpoints (T2D incidence and remission, cardiovascular events, mortality). 
Ensuring micronutrient adequacy by food selection or supplementation should be considered 
for people who wish to pursue long-term LCDs.  
  
Low and reduced carbohydrate diets – challenges and opportunities for type 2 diabetes 1 
management and prevention 2 
 3 
Introduction  4 
Low-carbohydrate diets (LCD) have been heavily promoted for weight management, and as a 5 
possible strategy for type 2 diabetes (T2D) management and prevention (1-3). Current and emerging 6 
evidence from randomised trials remains inconclusive regarding the effectiveness of LCDs for health 7 
benefits (via weight control or metabolic control) (4). As with any restrictive diet, the long-term 8 
sustainability of LCDs has been questioned, with additional concerns over safety, by comparison 9 
with current usual western diets or with alternative dietary recommendations (5-7). This review 10 
explores the current evidence and debates which supports or challenges the use of LCDs for T2D 11 
management and prevention. 12 
 13 
Type 2 diabetes: a disease process of obesity 14 
T2D is primarily a nutritional disease, which used to be rare in pre-industrial societies, but is now 15 
emerging as one of the most common and damaging chronic diseases. Its global prevalence has 16 
approximately doubled from 1980 to 2014, in line with rising overweight and obesity (8). It causes 17 
1.6 million premature deaths annually, and shortened lives often end with years of pain and multiple 18 
disabilities (9).  19 
 20 
The extraordinary association between T2D and elevated body mass index (BMI; not simply 21 
BMI >30 kg/m2) was shown graphically in the prospective Nurses Health Study. Compared to BMI 22 
<22 kg/m2, women with a BMI 23-23.9 kg/m2 had a 3.6-time higher relative risk of incident T2D, 23 
rising to ~60 times higher risk in women with a BMI ≥35 kg/m2, levels strongly indicative of a 24 
causal relationship (10, 11). Excessive body fat accumulation is the critical, but reversable factor 25 
underlying T2D and metabolic syndrome development. In people who are predisposed (for genetic 26 
and other reasons), fat accumulates in ectopic sites including liver and pancreas, which damages 27 
organ functions (12), (Figure 1). Reversing that process by weight loss of at least 3-7% is a key 28 
mechanism to prevent or delay onset of T2D (13-16), and remission of established T2D can be 29 
achieved by greater loss, >15% for greatest success, with an intensive weight management program 30 
(17).  31 
 32 
Lifestyle modification, through dietary change and increasing physical activity, to halt or delay the 33 
disease-process which is driven by weight gain and excess body fat in susceptible individuals, is 34 
fundamental for T2D prevention and management (13). Advice and support for affected individuals 35 
can be very effective (17, 18) but is strongly undermined by effective social marketing driving greater 36 
energy intake, while physical activity continues to fall in the post-industrial environment (19). Self-37 
reported food consumption by individuals with overweight and obesity can also be misleading, with 38 
notable underreported food energy intake (~100 kcal/day) in adults with BMI >30 kg/m2 (20, 21). 39 
Meanwhile, food disappearance data show consistent positive relationships between rising obesity, 40 
increasing energy intake and consumptions of all food groups and all macronutrients (22-25).   41 
 42 
Role of carbohydrate in the diet 43 
A primary role of carbohydrates is to serve as main and preferable source of body energy, 44 
contributing toward approximately half of energy intake per day at population level (26, 27). 45 
Carbohydrate-rich foods, consumed regularly everyday as part of our main diets, are considered 46 
staple foods, including potatoes, rice and wholegrains, breads, pasta. Carbohydrates are also found in 47 
fruits, milk, beans and some starchy vegetables (28). After consumption, foods containing 48 
carbohydrates are digested by the enzymes in the small intestine and absorbed in the form of glucose 49 
molecules. Glucose absorbed into the blood stream is transported into cells with the help of insulin, 50 
then directly converted to energy or stored as glycogen (28). Not all carbohydrates are digested in the 51 
small intestine, with undigested constituents passing to the large intestine (colon); these are classified 52 
as dietary fibre (28). Dietary fibre can be fermented by the resident bacteria in the large intestine, 53 
forming short-chain fatty acids, and also carry out a functional role through water absorption and 54 
bulking of stools (28). Carbohydrate-rich foods are also a good source of vitamins and minerals, as 55 
they come from plant-sources. In the UK, cereals and cereal products, vegetables and potatoes, and 56 
fruits are the major food groups contributing to vitamins and minerals intakes, either naturally 57 
presented or fortified, (Table 1) (26). 58 
 59 
Not all carbohydrates are the same, and types and quality matter. Eating carbohydrate-rich foods like 60 
wholegrain, whole-wheat pasta, brown rice, potatoes with skin, fruits and vegetables is associated 61 
with chronic disease risk reduction, which is partly explained by dietary fibre, found in plant cell 62 
walls (29). Fibre can help with body weight maintenance through regulation of energy balance and 63 
satiety (30, 31). Fibre also impacts on bowel health, with decreased risk of constipation (29). In contrast, 64 
consumption of free sugars (table sugar, fruit juice, honey, sugar-sweetened beverages, or sugary 65 
snacks) could result in excess energy intake leading to overweight and obesity (32).  66 
 67 
National nutrition surveys in the UK and USA found that ultra-processed foods (NOVA 68 
classification) accounted for 65-90% of energy intakes from sugars, and approximately 50% of total 69 
energy intake (33, 34). Ultra-processed foods often have high fat and salt contents, and include highly 70 
processed refined carbohydrates which are low in fibre (e.g. white flour) (35). A controlled in-patient 71 
metabolic ward RCT of ad libitum intake showed that more calories were consumed with a diet 72 
offering of ultra-processed foods, compared to unprocessed foods, resulting in 1 kg weight gain over 73 
2 weeks (36).  74 
 75 
What are low-carbohydrate diets? 76 
Prominent media coverage has promoted the idea that obesity and metabolic diseases derive almost 77 
entirely from consumption of sugar, and because all carbohydrates are digested as sugars, from any 78 
dietary carbohydrate. The promotion of very low-carbohydrate diets, with unlimited fat (including 79 
saturated fats) and protein stems from this paradigm; for example, the Atkins Diet, which limits 80 
intakes of bread, pasta, and rice, allows unlimited consumption of animal foods such as red meat and 81 
processed meat, high in saturated fatty acids (37). While calories from sugar (free sugar, added sugar) 82 
are largely unnecessary, total carbohydrate restriction could also entail avoiding health-promoting 83 
constituents of high-carbohydrate foods such as wholegrains.  84 
 85 
Definitions of ‘low-carbohydrate diets’ in the scientific literature vary, and may reflect either diets 86 
low in carbohydrate as percentage of energy intake, or low absolute daily consumption (grams) of 87 
carbohydrate. Commonly used definitions for humans range from intakes below 20% to below 45% 88 
of energy, and from below 60 g to below 120 g of carbohydrate daily (38-42). Some authors propose 89 
referring to ‘low-carbohydrate diet’ as carbohydrate below 40%(43) or 26%(1) of energy, and to ‘very 90 
low-carbohydrate diet’ when carbohydrate is under 20%(43) or under 10%(1) of energy, with no 91 
consensus to date (Table 2). The term ‘low-carbohydrate diet’ is commonly applied regardless of 92 
other macronutrient contents in the overall diet composition, which introduces variance in the 93 
constituent foods being used, and in metabolic responses. For example, a low-carbohydrate, high 94 
saturated fat diet increased LDL-cholesterol (44), whereas a low-carbohydrate, low saturated fat, high 95 
unsaturated fat diets showed no change in LDL-cholesterol (45). Another study of plant-based LCD 96 
with low saturated/high unsaturated fat contents also reported a reduction in LDL-cholesterol (46). 97 
 98 
In addition, there are many different commercial versions of the LCD, such as the Atkins Diet, Zone 99 
diet, or the South Beach Diet (47, 48). The most popular have been based on the Atkins Diet, with 17 100 
million copies of ‘Dr Atkins New Diet Revolution’ sold, and heavy promotion in the media and on 101 
the internet (37, 49, 50). This diet suggests 2 phases. The induction phase limits intake of carbohydrate 102 
to no more than 20 g, with liberal intake of fat and protein including red meat, butter and vegetable 103 
oils, and exclusion of bread, pasta, grains, fruits, other starchy vegetables and dairy products except 104 
cheese, cream and butter. Supplementary multivitamins and fibre are recommended. In the second 105 
phase, once a desirable weight has been achieved, daily carbohydrate intake can be increased to the 106 
level that can maintain weight (37). 107 
 108 
Hypothesis about low-carbohydrate diets and obesity and type 2 diabetes 109 
Common features among obesity, T2D and metabolic syndrome are hyperinsulinemia and insulin 110 
resistance. Instead of excessive total energy intake causing weight gain, insulin resistance and 111 
hyperinsulinemia, a carbohydrate-insulin model of obesity (CIM) hypothesises that carbohydrate 112 
intake, including refined starchy foods and sugars causes postprandial hyperinsulinemia, promotes 113 
lipogenesis leading to decreased level of metabolic fuels (glucose and lipids), and leads to weight 114 
gain through increased hunger and less energy expenditure (51). By this CIM, LCDs could reduce 115 
postprandial insulin secretion, promote fat loss, and decrease risks of chronic diseases (51).  116 
 117 
Weight loss with either LCD or low-fat diet (LFD) showed an improvement in insulin resistance, 118 
measured by intravenous glucose tolerance test (IVGTT) or euglycaemic hyperinsulinemic clamp (52, 119 
53). In contrast, non-weight loss, controlled feeding, short-term studies of very-low carbohydrate, 120 
high fat (high saturated fat) diets in healthy young men showed worsened insulin sensitivity, 121 
measured by oral glucose tolerance (54), IVGTT (55) and euglycaemic-hyperinsulinemic clamps (56, 57). 122 
On the other hand, short-term studies in healthy overweight and obese postmenopausal women (58), 123 
and men with T2D (59) showed no difference in insulin sensitivity by euglycaemic-hyperinsulinemic 124 
clamp between LCD and LFD, this might be explained by the unsaturated fatty acids used to replace 125 
carbohydrate (60).  126 
 127 
The evidence of LCDs on beta-cell function is limited. One short term crossover RCT of LCD vs. 128 
normal diet showed a reduction in first-phase insulin response after 3-day of very low-carbohydrate, 129 
high-fat diet in healthy young men (54). In animal studies, long-term ketogenic diets in mice showed 130 
an increased insulin resistance, did not prevent beta-cell mass decline (61), and even showed a 131 
reduction in beta-cell mass, including smaller size of islets (62). Although LCDs could reduce 132 
postprandial glucose and postprandial insulin response, without weight loss, the limited evidence 133 
fails to support that LCDs could reverse pathophysiology of hyperglycaemia in obesity and T2D. 134 
 135 
Opportunities for the use of low-carbohydrate diets for diabetes prevention in individuals with 136 
overweight and obesity, who are at high risk of type 2 diabetes 137 
Weight management, either weight loss or weight maintenance, plays the biggest role in T2D 138 
prevention in individuals with overweight and obesity. Several large ‘diabetes prevention’ trials have 139 
shown a clear benefit on T2D risk reduction principally by modest weight loss mainly by lowering 140 
fat intake (<30%E). Other lifestyle modifications have more modest value (13-16). While weight loss 141 
by LFD has been largely incorporated in ‘diabetes prevention’ trials, the randomised controlled trials 142 
(RCT) of LCDs for weight loss do not have long enough follow-up to evaluate incident T2D and 143 
were not designed to study incident T2D as a primary outcome. As weight loss is an essential 144 
mechanism for T2D risk reduction, this section also discusses the role of LCDs in weight loss. 145 
 146 
The idea of LCDs for weight loss first attracted public interest with the letter of William Banting 147 
published in 1863 describing his successful personal weight loss of 46 lbs (~20 kg), from 202 lbs to 148 
156 lbs over a 12-month period, by cutting bread, potato, pastry, milk, sugar, and a majority of fruits 149 
(63). Several anecdotal reports of similar success have been discussed in the media (64-66), highlighting 150 
that the successful weight loss stories with LCDs could be subject to survival bias, with the 151 
experience of those who tried and failed not being reported. LCDs can achieve a mean weight loss of 152 
7 kg approximately over 6-24 months, up to 10% of baseline body weight in non-controlled studies 153 
(67-70). LCDs, however, certainly work for some, as highlighted in the DIETFITS study that 154 
participants who assigned to LCD group lost a maximum of 30 kg body weight, while some 155 
participants gained up to 10 kg body weight (42). 156 
 157 
Randomised controlled trials and meta-analyses evidence of low-carbohydrate diets for weight loss 158 
Several RCTs and meta-analyses have been conducted to examine the effects of LCDs for weight 159 
loss, compared to LFDs (71-73). The conclusion has repeatedly been that there may be marginally 160 
greater weight loss in the short term (approximately the 2 kg expected from depletion of glycogen 161 
and its associated water), but no consistent superiority of LCDs over the longer term (4). At 6 months 162 
(Figure 2A), meta-analyses reported that weight loss from LCDs was greater than LFDs by 0.7 to 4 163 
kg, but this difference dropped to 0.5 to 1 kg at 12 months, Figure 2B (4, 40, 41, 47, 71, 74).  164 
 165 
Factors contributing to inconsistent findings among published meta-analyses of low-carbohydrate 166 
diets and low-fat diets for weight loss 167 
Our recent systematic review of published meta-analyses (4) explores these inconsistent findings 168 
regarding the effectiveness of LCDs and LFDs for weight loss, partly explained by large differences 169 
in methodology. Definitions of what constitutes LCDs varied among meta-analyses, ranging from 20 170 
g/d to <45% energy from carbohydrate. The more extreme carbohydrate restriction (20-60 g/d or 10-171 
20%E) resulted in greater weight loss compared to LFDs (4). With unrestricted energy LCDs, 172 
participants typically consumed 30% less total energy than baseline, resulting in a greater weight loss 173 
over 3-6 months (72, 73, 75). The weight loss is then attenuated over time (12 months or more), probably 174 
via loss of adherence, as commonly occurs in weight loss trials in free-living participants who tend to 175 
return to their previous diet and lifestyle in the obesogenic environment (76, 77).  176 
 177 
Quality and bias among published meta-analyses of low-carbohydrate diets and low-fat diets for 178 
weight loss 179 
We also assessed quality of each published meta-analyses using AMSTAR 2 criteria (78). Contrasting 180 
with the wide popularisation and mediatisation of LCDs, only two meta-analyses were ‘high quality’ 181 
(n=2/10) and they reported no weight loss difference compared to LFD, while half (n=5/10) were of 182 
‘critically low quality’ but reported LCD superiority over LFD for weight loss, up to 4 kg difference 183 
(4). Of particular interest, meta-analyses favoring LCDs but of low-quality also had higher citations 184 
(rho = -0.9, p=0.037), suggesting that public and scientific communities might be responding most to 185 
findings generated through poor methodology (4). Despite featuring at the top of the evidence 186 
hierarchy, meta-analyses remain open to biases. 187 
 188 
Predictors of weight loss: macronutrients and/or diet adherence - findings from controlled feeding 189 
studies and free-living participants  190 
LCDs have been promoted on the basis that they theoretically reduce more body fat than LFDs, via 191 
lessened stimulation of postprandial insulin secretion, leading to lessened inhibition of lipolysis. This 192 
hypothesis is, to date, not supported by a meta-analysis of controlled feeding studies comparing the 193 
effect of isoenergetic LCDs vs. LFDs, with equal protein (79). A strength of the controlled feeding 194 
studies is of the by-passing of adherence as a confounder. The pooled results showed that LFDs 195 
yielded a 26 kcal/d greater difference in energy expenditure, and a 16 g/d greater loss in body fat 196 
change, compared to LCDs with equal protein (79). However, these differences are small and could 197 
not infer clinical impact of the effect of dietary fat and carbohydrate on body weight loss, when 198 
energy intake is equally held between the two diets. Consistent findings were also seen in weight loss 199 
trials in free-living participants. A meta-analysis of LCDs vs isoenergetic LFDs (74) reported little 200 
difference in body weight loss between the two diets at 3-6 months (mean difference -0.74 kg; 201 
95%CI -1.49 to 0.01) and 1-2 years (mean difference -0.48 kg; 95%CI -1.44 to 0.49). This highlights 202 
that caloric restriction and adherence to the program are superior for weight loss than macronutrients 203 
composition.  204 
 205 
Macronutrients, appetite and weight control 206 
Given that controlled metabolic studies find no difference in weight loss with low or high 207 
carbohydrate diets (79), the small short-term weight-loss advantage of LCDs over high-carbohydrate 208 
energy-restricted diets in free-living people may be due to greater ease, willingness or enthusiasm to 209 
restrict high-carbohydrate foods. High carbohydrate foods are also somewhat easier to identify (80, 81), 210 
as much fat in foods is hidden (e.g. in cakes, biscuits, muffin, pizza, cereal bars) (82), and this 211 
approach is currently heavily promoted via the mainstream and social media. In principle, restricting 212 
fat (9 kcal/g) should be more effective than restricting carbohydrate (4 kcal/g). It is however possible 213 
that the higher protein intake from Atkins-style LCDs could suppress appetite (83-86). 214 
A further oft-cited possibility is that the ketosis that develops with more extreme carbohydrate 215 
restriction, suppresses appetite (86, 87).  When body fat or dietary fat is oxidised, with weight loss or 216 
with a very high fat diet, the fat oxidation products ‘ketone bodies’ accumulate in the blood stream 217 
(e.g. β-hydroxybutyrate, 0.3-0.8 mmol/L on LCDs vs ~0.1 mmol/L on typical diets with 50%E 218 
carbohydrate) (88, 89).  Ketone body production is a biochemically necessary accompaniment of 219 
weight loss, and appetite usually increases with energy restriction and starvation (90, 91), as a powerful 220 
survival mechanism. Very limited evidence has examined the specific effect of raising ketone bodies 221 
to be able to confirm or refute this theory, which is highly relevant to sustainability of carbohydrate 222 
restriction and appetite control. Stubbs et al. (92) recently published a crossover RCT of exogenous 223 
ketone (via a ketone ester drink) compared to a dextrose drink. Ketone ester ingestion markedly 224 
increased blood β-hydroxybutyrate level from 0.2 to 3.3 mM after 60 minutes, and suppressed 225 
reported hunger and desire to eat (both measured by visual analogue scales) by 50% compared to a 226 
dextrose drink, 1.5 to 4 hours postprandially (92). 227 
There is current interest in the evidence that some carbohydrates, functioning as dietary fibre, can 228 
suppress appetite and weight gain by releasing short-chain fatty acids, which stimulate GLP-1 release 229 
from the large intestine, through the action of gut microbes (93). Dietary inulin-propionate ester is 230 
metabolised by gut microbes to deliver propionate to the large intestine (94, 95). Propionate acutely 231 
stimulates GLP-1 production resulting in appetite suppression and decreased energy intake (93). 232 
However, the effect on GLP-1 release is not well sustained over time, while the effect on appetite 233 
suppression is maintained (93), suggesting that other mechanisms unrelated to GLP-1 may operate 234 
(96). Other physical effects of dietary fibre (e.g. viscosity, gel formation) could also play a role in 235 
appetite suppression (97). Although the underlying mechanism of dietary fibre and appetite 236 
suppression is not fully confirmed, the collective evidence would support the use of high fibre diets 237 
for weight control (93-95, 97, 98). Figure 3 illustrates the levels of ketones, propionate and satiety in 238 
relation to carbohydrate and dietary fibre intakes. 239 
 240 
Opportunities for the use of low-carbohydrate diets as a treatment strategy for patients with 241 
type 2 diabetes 242 
Controlling blood glucose within a desirable range, evaluated via measurement of HbA1c, is a 243 
primary aim for T2D management (99, 100). LCDs have been postulated to have physiological benefits 244 
over higher carbohydrate diets for HbA1c reduction. A lower postprandial glucose excursion would 245 
be expected after LCDs, compared to higher carbohydrate diets if they present greater glycaemic 246 
index or glycaemic loads (66, 101). A reduced postprandial excursion should lead to a better overall 247 
glucose control and lower HbA1c. Recent clinical guidelines recommend individualised nutrition 248 
therapy for people with T2D, and allow flexibility of carbohydrate intake to suit personal preferences 249 
and metabolic goals (99, 100). However, the role of LCDs in T2D remain unclear and often yield mixed 250 
results (102-104). This is likely to be influenced by level of energy restriction, and protein/fat 251 
composition of the diets. 252 
 253 
Randomised controlled trials and meta-analyses evidence of low-carbohydrate diets for blood 254 
glucose control 255 
Meta-analyses of LCDs in patients with T2D have showed little greater reductions in HbA1c 256 
compared to higher-carbohydrate diets, by 0.17% to 0.34% over short term period up to 6 months 257 
with evidence grades ranging from very-low to moderate certainty (102-104). Notably, results from 258 
RCTs with <6 months duration showed that a lower carbohydrate intake was associated with a 259 
greater extent HbA1c reduction (r = -0.8, p<0.01) (104), this could be explained by a greater weight 260 
loss following LCDs within 6 months duration(4, 102, 103).  However, there is no difference in HbA1c 261 
reduction between the two diets at 12 months or longer (102-104). The definitions of LCDs in those 262 
meta-analyses were <45%E from carbohydrates, which departs from more conservative definitions. 263 
More importantly, the difference in HbA1c reduction between the two diets is of unclear clinical 264 
importance, with a majority of RCTs included in those meta-analyses with high risk of bias (102, 103).  265 
 266 
Randomised controlled trials evidence for type 2 diabetes remission 267 
There have been debates on the definitions of remission of T2D (105, 106). While there is no consensus 268 
on the remission criteria, it is obvious that blood sugar, both HbA1c and fasting blood glucose, 269 
should be below the diagnostic threshold for diagnosis of T2D. To date, there is no RCT to study the 270 
effect of LCDs on T2D remission, and clinical trials aiming at T2D remission outcome were also 271 
limited with unclear report on remission rate and criteria (69, 88). A single-arm longitudinal study of a 272 
Low-Carb Program in patients with T2D reported a 1-year result that 26% of patients (n=195/743) 273 
had HbA1c below 6.5%, with either metformin or no prescribed diabetes medication (69). Another 274 
non-RCT (Virta Health study) also reported that 25.5% (n=52/204) participants in the LCD group 275 
(carbohydrate <30 g/d, with behavioral therapy and frequent follow-up) had HbA1c below 6.5% 276 
without prescribed diabetes medication at 1 year of intervention (88). 277 
 278 
Weight loss masking the effect of low-carbohydrate diets on blood glucose improvement and type 2 279 
diabetes remission 280 
HbA1c reduction and T2D remission following LCDs have been largely confounded by weight loss 281 
(69, 88, 102-104, 107), leaving considerable doubt over the benefit for HbA1c which can be attributed to 282 
carbohydrate quantity per se. Most evidence featuring in meta-analyses comparing the impact of 283 
LCDs and LFDs on HbA1c was weight loss trials (69, 88, 102-104). Similarly, the Virta Health study 284 
showed a reduction in HbA1c, from 7.6% to 6.3%, along with a mean weight loss of 14 kg in 285 
patients with T2D (88).  286 
 287 
Evidence of LCDs in non-weight loss trials is limited. A crossover RCT of a low-carbohydrate, high-288 
protein diet (LCHP; 30%E carbohydrate, 30%E protein) vs. an isoenergetic conventional diabetes 289 
diet (CD; 50%E carbohydrate, 17%E protein) reported a greater reduction in HbA1c in the LCHP 290 
group (-0.6 ± 0.1%) compared to the CD group (-0.1 ± 0.1%; p<0.001) (108). This study, however, is 291 
limited by a small sample size (n=28), short duration (6 weeks for each diet), and no washout period 292 
- which could not exclude carryover effect. More importantly, greater weight loss was reported in the 293 
LCHP group (-1.4 kg) than the CD group (-0.8 kg; p=0.07) (108). Another crossover RCT of LCHP 294 
diet vs. LFD (n=8; 5 weeks) also showed a greater reduction in HbA1c following LCHP, but it is 295 
noted that there was a 2 kg weight loss during the 5-week study duration regardless of diet (109). The 296 
greater HbA1c reduction following LCHP could be attributed to the insulinotropic effect of high 297 
protein intake (110-113). The results, therefore, needs to be confirmed by larger and longer duration 298 
RCTs.  299 
 300 
Randomised controlled trials evidence for vascular and renal function in type 2 diabetes 301 
Long-term RCT evidence on the safety of LCDs is limited. One RCT comparing very low-302 
carbohydrate, low-saturated fat diet vs. low-fat, low-saturated fat diets in patients with T2D and no 303 
pre-existing kidney disease reported that no difference was found in vascular function determined by 304 
flow mediated dilatation that might be explained by these two diets had similar level of saturated 305 
fatty acids (114). Regarding renal function, a meta-analysis of nine RCTs of LCDs and LFDs for 306 
weight loss showed that a mean change in an estimated glomerular filtration rate following LCDs 307 
was little greater than LFDs by 0.13 ml/min per 1.73m2, with duration up to 1-2 years (115).  308 
 309 
Dietary recommendations for patients with type 2 diabetes 310 
While there is no ideal amount of carbohydrates for patients with T2D, a guideline emphasises 311 
reduction of refined carbohydrates and added sugars, and focus on carbohydrates from vegetables, 312 
legumes, fruits, dairy (milk and yogurt), and whole grains, in order to achieve healthful eating 313 
patterns with a variety of nutrient-dense foods (99). If patients prefer LCDs, this approach should be 314 
only used for a short-term, up to 3-4 months, due to limited evidence on long-term benefits and 315 
harms of LCDs (99). 316 
  317 
Challenges associated with the use of low-carbohydrate diets 318 
Low-carbohydrate diets and micronutrients 319 
While weight is often the main outcome, nutritional quality of all diets should be a key primary 320 
concern. As key characteristic of LCDs, avoidance of wholegrains, fruits and starchy vegetables 321 
could reduce vitamins, minerals, as well as plant bioactives (which play a role in the modulation of 322 
glycative stress (116, 117), relevant to T2D pathophysiology). The negative impact of LCDs on 323 
micronutrients has often been neglected. Our systematic review (118) found 7 RCTs (73, 119-124), 2 non-324 
controlled trials (125, 126), and 1 cross-sectional study (127) reporting rather consistent reductions in 325 
thiamine (vitamin B1), folate, vitamin C, magnesium, calcium, iron, and iodine intakes (118). 326 
Although there is no definitive guidance for supplementation during LCDs, only one study provided 327 
supplementation to participants (126). Most of the studies included did not report on supplements used 328 
in their studies (118). It is therefore difficult to assess whether inadequate micronutrient intakes have 329 
been topped-up by supplementation (118). 330 
 331 
This could have clinical consequences. For example, severe thiamine deficiency and beriberi are 332 
well-recognized with prolonged extreme LCDs (128, 129). Inadequate intakes of folate and iodine in 333 
women of child-bearing age could increase risk of poor foetal outcomes (130). Gardner and colleagues 334 
showed that individuals on the Atkins Diet had lower intake of thiamine and magnesium over 8 335 
weeks (120). Unfortunately, there have been case reports of thiamine deficiency from following a 336 
LCD. Bilateral optic neuropathy was reported in two patients who followed a prolonged 337 
carbohydrate-restricted diet (128). Another case of Wernicke’s encephalopathy and cardiac beriberi 338 
was reported in a patient with obesity who restricted breads and pasta from his diet (129).  339 
 340 
Low-carbohydrate diets and low-density lipoprotein cholesterol 341 
Lipid disturbance is commonly seen in individuals with overweight and obesity, including those with 342 
T2D, who are at high risk of atherosclerotic cardiovascular diseases (ASCVD). High triglyceride 343 
(TG) and low high-density lipoprotein (HDL) cholesterol are risk factors of ASCVD, while high 344 
low-density lipoprotein (LDL) cholesterol is a main culprit of ASCVD, depositing in arterial wall, 345 
initiating plaque formation and progression of ASCVD (131, 132). There has long been a concern about 346 
increasing LDL-cholesterol following LCDs, albeit balanced by decreasing TG level (4).  347 
 348 
Evidence from weight loss trials showed that LCDs increased LDL-cholesterol to a greater extent 349 
compared to LFDs (by 0.1 to 0.4 mmol/L – or 4 to 16 mg/dL) over 6 to 24 months intervention (38-41, 350 
71, 133). The lower carbohydrate component in the diet may be associated with a greater increment in 351 
LDL-cholesterol level, as seen in a cohort of patients with T2D following ketogenic diets (<30 g/d of 352 
carbohydrate) that LDL-cholesterol increased by 10% after 1 year of the diet (88). In non-weight loss 353 
studies (44, 89, 134), low-carbohydrate, high fat, high saturated fat diets (18-25%E saturated fat) for 3-4 354 
weeks, showed 17-21% increment in LDL-cholesterol from baseline, including increments in small 355 
and medium LDL participles (44, 89). 356 
 357 
Most importantly, there were two case reports of acute coronary syndrome in patients following the 358 
Atkins Diet. A 51-year-old man, healthy, physically active, no previous heart disease, diabetes, 359 
hypertension or dyslipidaemia developed marked change in LDL-cholesterol, from 2.2 mmol/L (85 360 
mg/dL) at 6 months prior to the Atkins Diet to 4 mmol/L (154 mg/dL) at 1 month after the diet, BMI 361 
21.8 kg/m2, despite a 3 kg weight loss. The patient remained on this diet until 29 months later when 362 
he experienced exertional chest pain, and his cardiac catheterisation demonstrated a severe stenosis 363 
of the left anterior descending artery (135). Another case report was a 41-year-old man, who had no 364 
ASCVD risks and no family history of premature coronary artery disease. His BMI was 19.5 kg/m2. 365 
The patient adhered to the Atkins Diet for 6 years with repeated cycles each year. His blood lipids, 366 
apoliprotein A and homocysteine levels were within normal limits. He presented with acute chest 367 
pain in which the investigation showed an acute myocardial infarction (136).  368 
 369 
Low-carbohydrate diets and ketoacidosis 370 
Ketosis is associated with, and largely causes, dangerous acidosis (ketoacidosis) in poorly treated 371 
insulin-deficient type 1 diabetes.  Apart from micronutrient inadequacies and increased LDL-372 
cholesterol, ketosis usually develops in individuals following LCDs (88). Although there is no severe 373 
ketacidosis reported in clinical trials, there is a case report of ketoacidosis in a non-diabetic lactating 374 
woman following a ketogenic diet with <20 g/day of carbohydrate. The patient developed nausea and 375 
vomiting after 10 days of the diet. Serum pH was 7.2 indicating acidosis, with blood ketones of 7.1 376 
mmol/L (reference <0.5 mmol/L). The authors hypothesised that lactation could aggravate or trigger 377 
ketoacidosis: during lactation, women require increased energy intake to meet the high demand of 378 
substrate to produce milk.  Fat, whether stored or dietary, is the primary resource of energy during a 379 
ketogenic diet, and thus responsible for ketoacidosis (137). 380 
 381 
Long-term epidemiological evidence on low-carbohydrate diets, type 2 diabetes, cardiovascular 382 
risks and mortality 383 
Intervention studies comparing LCDs and LFD have shown little or no difference on weight change 384 
over 1-2 years, but do not have long enough follow-up to study the clinical outcomes such as 385 
incident T2D, cardiovascular diseases, and mortality, or long-term safety.  386 
 387 
Low-carbohydrate diets, HbA1c level and incident type 2 diabetes 388 
Our cross-sectional analysis in people without known diabetes in the National Diet and Nutrition 389 
Survey (NDNS, UK) showed that, although few people (n=8, or 0.24% of the overall sample) met 390 
the conservative definition of LCD (<26%E), both lower carbohydrate intake (per 5%E band) and 391 
LCD pattern (according to LCD adherence score), were associated with higher HbA1c (+0.16 392 
mmol/mol, p=0.012, per 5%E decrease in carbohydrate; +0.10 mmol/mol, p=0.001, per 2-point 393 
increase in LCD adherence score) (138). The NDNS used food diaries for estimation of dietary 394 
intakes, which are more accurate and less reliant on memories compared to the food frequency 395 
questionnaires (FFQ). While the study design does not inform cause and effect, the findings are to 396 
some extent in line with longitudinal studies (139, 140). This evidence indicates that it is unlikely that 397 
consuming lower carbohydrate content per se could lower HbA1c level. Other mechanisms (e.g. 398 
oxidative stress, peripheral insulin resistance) could contribute to HbA1c elevation, as high oxidative 399 
stress can enhance protein glycation without hyperglycaemia (141).  400 
 401 
When looking at incident T2D and LCDs, the most recent cohort study in Australian women showed 402 
a 27% higher risk of T2D with LCD (comparing extreme quartiles, with absolute risk increase of 403 
~3%), although the relative risk (RR) was attenuated to 10% after adjustment for BMI (142). A meta-404 
analysis of 11 prospective cohort studies showed that different regions had different outcomes (143). 405 
In Europe (144-147), LCDs increased the T2D risk by 12% (pooled RR 1.12; 95% CI 1.04-1.20), 406 
whereas in Japan (148) and China (149), LCDs decreased the T2D risk by 20% (pooled RR 0.80; 95%CI 407 
0.70-0.90) (143). The pooled result in Asian countries was explained by white rice as a key food 408 
source of (refined) carbohydrate, a major component in Japanese and Chinese diets (148, 149). A study 409 
showed that substituting white rice with brown rice or wholegrain could result in T2D risk reduction 410 
by 16% and 36% respectively (150).  411 
 412 
Sources of protein and fat in replacing for carbohydrate also contributed to T2D risk. LCD with high 413 
animal protein and fat was associated with a 37% increase in T2D risk in men (95% CI 1.2 – 1.58; p-414 
trend <0.01) (139), and a 40% increase in T2D risk in women with history of gestational diabetes 415 
(95% CI 1.06 – 1.84; p-trend = 0.004) (151). On the other hand, LCD with vegetable protein and fat 416 
was associated with a 18% T2D risk reduction in women (95%CI 0.71 – 0.94; p-trend = 0.001) (152). 417 
Contrary findings between men and women could be explained by sex differences in T2D 418 
susceptibility (153). Pre-menopausal women are less susceptible to T2D than men, partly explained by 419 
difference in sex steroid hormones (153). Endogenous oestrogen plays a protective role in various 420 
metabolic regulations including insulin secretion and sensitivity, although the underlying mechanism 421 
has yet to be explored (153). Women have higher capability for lipid utilisation, favouring 422 
subcutaneous adipose tissue as an energy storage, preventing them from ectopic fat accumulation 423 
(153). 424 
 425 
Low-carbohydrate diets and cardiovascular diseases 426 
In the prospective cohort Nurses Health Study of 82,802 women, diets were assessed by a validated 427 
FFQ and a calculated ‘LCD score’ (higher scores representing higher intakes of fat and protein, and 428 
lower intake of carbohydrate). During the 20 years follow-up, a higher LCD score (10th decile vs. 1st 429 
decile) was associated with a 29% increased risk of coronary heart disease (CHD) (age-adjusted RR 430 
1.29; 95% CI 1.04-1.60). After adjustment for body mass index, smoking status, physical activity, 431 
history of diabetes and hypertension, the adjusted RR for CHD was attenuated to 0.94 (95%CI 0.76-432 
1.18, p for trend 0.19). Interestingly, when analysing the LCD score based on vegetable protein and 433 
vegetable fat, the adjusted RR of CHD was 0.70 (95% CI 0.56-0.88; p for trend 0.002) whereas when 434 
animal protein and animal fat were chosen, the adjusted RR was 0.94 (95% CI 0.74-1.19; p for trend 435 
0.52) (154). When using a composite outcome of cardiovascular events (ischemic heart disease, 436 
ischemic stroke, haemorrhagic stroke, subarachnoid haemorrhage and peripheral arterial disease), a 437 
large cohort study of 43,396 Swedish women reported that every 2 units greater in the low-438 
carbohydrate, high-protein diet score was associated with a 5% increase in the incidence of 439 
cardiovascular events (incidence rate ratio 1.05; 95%CI 1.02-1.08) (155).  440 
 441 
LCDs are also associated with increased risk of incident atrial fibrillation (156). Findings from a large 442 
prospective community-based cohort study (Atherosclerosis Risk in Communities, ARIC Study) 443 
showed that every 9.4% higher in carbohydrate intake as percentage of energy (1-standard deviation) 444 
was associated with reduced risk of incident atrial fibrillation by 18% (adjusted hazard ratio (HR) 445 
0.82; 95% CI 0.72 – 0.94), while there was no association found between animal and plant sources of 446 
protein and fat and incident atrial fibrillation (156). These contrasting findings highlight the need to 447 
pay greater attention to the foods (and nutrients) replacing carbohydrates in LCDs. 448 
 449 
Low-carbohydrate diets and mortality 450 
Several prospective cohort studies and their meta-analyses showed consistent findings that LCD 451 
pattern was associated with increased risk of all-cause mortality and cardiovascular mortality (157-163). 452 
The ARIC Study found a U-shape association between carbohydrate intake (%E) and all-cause 453 
mortality, with the lowest mortality risk at 50-55%E carbohydrate. The authors also conducted the 454 
meta-analysis for carbohydrate and mortality (162-164). Compared to moderate carbohydrate intake 455 
(~50%E), low carbohydrate intake (<40%E) was associated with a 20% increased risk of all-cause 456 
mortality (pooled HR 1.2; 95%CI 1.09-1.32; p<0.0001), and high carbohydrate intake (>70%E) was 457 
also associated with a 23% increased risk of all-cause mortality (pooled HR 1.23; 95%CI 1.11-1.36; 458 
p<0.0001) (163). The meta-analysis also showed that mortality increased by 18% when replacing 459 
carbohydrate with animal-sourced fat and protein, and decreased by 18% when replacing 460 
carbohydrate with plant-sourced fat and protein (163). Another population-based cohort study also 461 
showed a 22% increased risk of all-cause mortality, a 13% increased risk of ASCVD mortality, and 462 
an 8% increased risk of cancer death in associations with LCD pattern (comparing between extreme 463 
quartiles, adjusted for BMI) (5).  464 
 465 
Analysis of the combined databases of the Nurses Health Study and the Health Professional Follow-466 
Up Study was performed in the population of post-myocardial infarction survivors (165). Those in the 467 
highest quintile of the LCD score from animal-sourced protein and fat had a 33% higher risk of all-468 
cause mortality (95%CI 1.06-1.65) and a 51% increased risk of cardiovascular mortality (95%CI 469 
1.09-2.07) than those in the lowest quintile (165). Interestingly, individuals who changed their diet 470 
from pre- to post-myocardial infarction towards LCD pattern was also associated with higher all-471 
cause and cardiovascular morality by 30% and 53% respectively.(165) 472 
 473 
Real world data on the use of low-carbohydrate diets 474 
Evidence documenting the use of LCDs outside clinical trials remains scarce. In the UK, an 475 
estimated three-million people have tried LCDs, accounting for 7-10% of respondents in a media 476 
poll (49), similar to a finding of 7% from a population-based survey in Finland (166), while it was up to 477 
17% in a nationally representative samples from the Health Information National Trends Survey in 478 
the USA (3). A survey of individuals following LCDs (in the Active Low-Carber Forum, an online 479 
support group for LCDs in the USA) reported that Atkins-style diets ranked top of LCDs used, 480 
accounting for 74% of reports (167). Two-third of respondents had lost 30 lbs in weight, or more (167). 481 
Avoiding sugar (94%) and avoiding starch (84%) were important factors for weight loss plan, while 482 
only 12% of respondents thought that ‘decreasing fat’ was an important factor (167).  483 
 484 
There is limited evidence for the use of LCDs in clinical practice. Dr Unwin et al. reported a case 485 
series of 19 patients with T2D and pre-diabetes who participated in a LCD program from one general 486 
practice (70). The LCD advice was to reduce all starchy carbohydrate foods (e.g. breads, pasta, rice), 487 
tropical fruits and vegetable oils, while promoting consumptions of green vegetables, berries, meat, 488 
eggs, fish, olive oil, coconut oil and butter. Patients were also advised to consume processed meat 489 
like sausages, bacon, ham, in moderation. One patient withdrew at the initial stage for personal 490 
reason. Of 18 patients, mean weight loss was 8.6 ± 4.2 kg (p<0.0001), and HbA1c dropped 491 
significantly from 51 ± 14 to 40 ± 4 mmol/mol (p<0.001) over 8 months period (70). Although this 492 
report was of small sample size with no control diet, it emphasised that LCDs can be effective for 493 
weight loss and glucose control, and can be implemented in clinical practice. Long-term data of 494 
LCDs in patients with T2D in primary care has the potential to depict both benefits and risks on hard 495 
clinical outcomes especially CVD events, renal adverse effects, and even mortality. The role of the 496 
healthcare practitioner as a source of support is also an important consideration in the context of this 497 
work. 498 
 499 
Real-world data on dietary intakes in self-reported LCD followers are also limited (127, 168). A recent 500 
cross-sectional study from Iceland with 54 self-reported LCD followers (80% overweight and 60% 501 
with elevated LDL-cholesterol level) demonstrated further insight into nutrient intakes (127). Median 502 
intake of carbohydrate was very low (only 8%E) while median fat intake was very high at 68%E, 503 
with 25%E from saturated fatty acid. Consumption of whole grain was only 5 g/day and fibre only 504 
11 g/day. Vegetable intake was of 170 g/day compared to 120 g/day of general population – this 505 
shows that vegetable intake is an important source of fibre in the context of LCD, requiring further 506 
emphasis (beyond the simple 5-a-day message) when carbohydrate-rich foods are limited or 507 
excluded. Red meat intake was 130 g/day, nearly double the intake of the general population in 508 
Iceland. Approximately half of participants had intakes of vitamin A, thiamine, folate, vitamin C, 509 
calcium, iron, and magnesium lower than recommendations. In contrast, 75% of participants 510 
consumed greater sodium than recommended (2400 mg per day) (127). 511 
 512 
As such, healthfulness of LCDs is highly dependent on choices of the foods to restrict but also foods 513 
to include and promote. As practiced, LCDs may not be a healthful, nutritionally-replete dietary 514 
approach, unless great care is taken to balance intakes. In USA, LCD followers had a healthy eating 515 
index score lower than those with higher carbohydrate diets (58.2 vs. 70.4, p=0.012) (168). Only half 516 
of LCD followers had support from their doctors, and two-thirds valued information from online 517 
supporting websites instead of government websites/publications (167). Our own work is currently 518 
seeking to establish a clearer picture of such practice (Churuangsuk et al., in preparation). Figure 4 519 
summarises the opportunities and challenges presented by LCDs in T2D management and 520 
prevention. 521 
 522 
Limitations of current research 523 
The well-known limitation of the RCTs of LCDs is the absence of evidence for long-term 524 
effectiveness on hard clinical outcomes like incident T2D, cardiovascular events, and mortality, 525 
instead of weight loss. Regarding T2D management, remission should be a primary aim for T2D 526 
treatment especially in early T2D, and high quality RCTs of LCDs aiming at T2D remission in 527 
comparison to other weight loss diets or routine care are needed.  528 
 529 
RCTs and epidemiological evidence showed that selection of food choices/sources of protein and fat 530 
could have different effects on health, but limited RCTs on the effect of food choices/sources of 531 
protein and fat in replacing carbohydrate have been conducted (45, 46). It is possible to design a 532 
healthful LCD with complete micronutrient profile and no detrimental effect on LDL-cholesterol  (45, 533 
46, 169), but this may require close supervision by dietitians in collaboration with other health care 534 
professionals. 535 
 536 
The ongoing debate on the usefulness of FFQ as a dietary assessment tool in epidemiological studies 537 
has highlighted the pitfalls associated with poorer accuracy of nutrient intake estimation and reliance 538 
on memory for recall. While FFQs are practical in the context of large sample sizes (e.g. population-539 
based study) and to rank dietary data, carbohydrate intake reports generate via this method should be 540 
evaluated carefully. While the epidemiological evidence to date shows detrimental effects of LCDs 541 
on health, the amount of carbohydrate consumed are usually higher than intakes relevant to 542 
individuals following (very) low carbohydrate intake, <20-30%E. Real-world data in self-reported 543 
low-carbohydrate dieters may help better elucidate the relationship between LCDs, dietary habits and 544 
long-term health status. 545 
 546 
Conclusions 547 
RCTs clearly show the efficacy of LCDs for weight loss in people with obesity and/or T2D, leading 548 
to glycaemic improvement. Their efficacy, however, is little different to that of higher carbohydrate 549 
diets or other weight loss diets with less drastic restriction of whole food groups. Many studies show 550 
only short-term benefit when compared to higher carbohydrate diets. LCDs may be preferred by 551 
some people, and have value at least for short-term results, but may potentially lead to micronutrient 552 
deficiencies and increased LDL-cholesterol, and there are longer-term risks of T2D and 553 
cardiovascular diseases. Ensuring dietary micronutrient adequacy through food fortification or 554 
supplementation should be considered for all who wish to pursue or prescribe long-term LCDs. Food 555 
choices in replacement of carbohydrate source may alleviate the negative effects of LCDs, but 556 
evidence on this topic remains limited. Evidence is lacking over whether the main energy source 557 
during LCDs should be fat or protein. Long-term, high-quality RCTs of LCDs with different food 558 
sources between animal and plants, aiming for hard clinical endpoints instead of weight loss are 559 
difficult to conduct, but needed to generate reliable advice.  560 
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Table 1 Percentage contribution of carbohydrate foods groups to average daily vitamins and minerals intakes in the UK adults 19-64 years 
(NDNS 2008-2014) 
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Cereals and cereal 
products 31 45 21 39 8 35 22 25 17 27 7 4 13 19 39 31 28 11 27 25 
Vegetables and 
potatoes  11 14 2 31 32 21 6 8 20 26 1 37 2 20 17 7 16 5 6 11 
Fruit 3 6 1 9 1 3 2 1 6 4 0 19 0 5 2 2 5 2 1 2 
Milk and milk 
products   9 5 6 1 14 6 28 7 8 7 33 6 5 4 1 36 10 33 6 15 
Sugar, preserves and 
confectionary 5 7 26 1 1 1 2 1 0 1 1 1 0 2 2 2 2 2 1 1 
CHO, carbohydrate; NSP, non-starch poly saccharides; Vit, vitamin; Ca, calcium; Mg, magnesium; I, iodine; Se, selenium; Zn, zinc;  
a from non-milk extrinsic sugars 
Colour code: in blue, macronutrients, energy and fibre; in green, micronutrients. Darker colours highlight a higher contribution of the good group to the UK adult intake for each 
specific nutrient, based on the UK NDNS data. 
  
Table 2. Proposed definitions of low-carbohydrate diets 
Categories Frigolet 2011 (43) Feinman 2015 (1) Examples 
Very low-carbohydrate 
(ketogenic) diet 
<20%E or 
<20-50 g/d 
<10% of the 2,000 kcal/d diet or 
20-50 g/d 
Atkins diet (Induction phase) 
Low-carbohydrate diet 20-40%E <26%E or 
<130 g/d 
Zone diet 
Moderate-carbohydrate diet - 26-45%E  
High-carbohydrate diet - >45%E  
E, energy; g/d, grams/day; kcal/d, kilocalories/day 
  
Figures legends: 
 
Figure 1: Schematic diagram of weight gain and type 2 diabetes (T2D) development 
 
Figure 2: Mean differences in weight loss between low-carbohydrate diets (LCD) vs. low-fat 
diets (LFD) at 6 months (A) and 12 months (B) of each meta-analysis (adapted from 
Churuangsuk et al. (4)) 
Horizontal axis indicates mean differences in weight loss in kilograms between LCD and LFD. The 
minus value indicates that LCD is more effective for weight loss than LFD. 
 
Figure 3: Proposed relationships between carbohydrates, dietary fibre, ketones and propionate 
levels, and satiety 
CHO, carbohydrates; E, energy 
 
Figure 4: Opportunities and challenges for low-carbohydrate diets in type 2 diabetes 
management and prevention 
Solid line indicates extensive and strong evidence. Dashed line indicates limited evidence. (+) 
indicates positive effect. (-) indicates negative effect. (?) indicates no sufficient evidence. 
LCD, low-carbohydrate diet; MUFA, mono-unsaturated fatty acids; PUFA, poly-unsaturated fatty 
acids; LDL, low-density lipoprotein; T2D, type 2 diabetes; CVD, cardiovascular disease.   
 
 
positive energy balance
excess fat accumulation in 
liver, pancreas, muscle
progression to T2D
insulin resistance & beta-cell dysfunction
environmental factors
e.g. smoking
weight gain
genetic/ethnicity
-6 -5 -4 -3 -2 -1 0 1 2
Naude 2014
Johnston 2014
Alexandraki 2015
Nordmann 2006
Hession 2009
Favor LCD        Favor LFD
-4 -3 -2 -1 0 1 2
Johnston 2014
Naude 2014
Alexandraki 2015
Bueno 2013
Nordmann 2006
Hession 2009
Favor LCD     Favor LFD
A B
S
a
ti
e
ty
Ketones Propionate
10%                                              50%CHO %E
LCDsWeight loss
Improve insulin resistance
Improve beta-cell function
↓ HbA1c
LCD high saturated fat
e.g. animal sourced 
protein & fat
-
-
Regain organ functions
&
LCD high protein
LCD high unsaturated fat
e.g. plant-sourced protein & fat
Potential micronutrient deficiency
+
Food choices & 
nutritional knowledge
↑ LDL-C
↑ risk of T2D
↑ risk of CVDs
↑ risk of Mortality
↓ LDL-C
↓ risk of T2D
↓ risk of CVDs
↓ risk of Mortality
Modifiers
MUFA vs. PUFA
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